New anticounterfeiting technology
A security technology, previously exclusively reserved for use by government organizations has become commercially available with major pharma manufacturers eager to adopt the device.
A security technology, previously exclusively reserved for use by government organizations has become commercially available with major pharma manufacturers eager to adopt the device. The product is expected to help fight against the counterfeit drugs market, a trade that is growing rapidly.
The Latentogram from ATB Security Technologies combines a holographic label incorporating a latent image, with a simple credit card-sized hand-held viewer. Looking at the hologram through the viewer reveals the hidden latent image, this establishing the authenticity of the product.
Despite not being as high-tech as other security products on the market, the product has advantages over other security devices. The cost of authenticating a product is reduced considerably, using only the hand-held reader, which is important for testing in developing countries where expensive security measures may not be available.
The technology allows the creation of textual and graphic images, photos and variable numeration within the hidden image.
Initial adoption for the device has been mainly in Eastern Europe, but the company has been in talks with several large pharmaceutical companies in the US.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
